Diffusion Pharmaceutical LLC
  • Email
  • Facebook
  • Twitter
  • Rss
  • Home
  • About
    • Introduction
    • Executive Summary
    • Management
    • Board of Directors
    • Investors
      • Investor Information Log-In
      • Potential Investor Registration
    • Intellectual Property
    • Useful Links
  • Cancer Treatment
    • Overview/The Problem
    • Treatment Resistance in Cancer
    • Tumor Sensitization and TSC
    • Preclinical Results
  • Clinical Trials
    • Clinical Trials Overview
  • Publications
    • Cancer
    • Cardiovascular and Stroke
    • Hemorrhagic Shock
    • Other
  • Programs
    • Program Overview
    • Glioblastoma Program
    • Brain Metastasis Program
    • Other Indications For TSC
  • News
    • Press Releases
    • Subscribe
  • Contact
    • Contact
    • Directions

News

  • Press Releases
  • Subscribe

News

  • Office: 434-220-0718
  • Contact Us
    • Facebook
    • Email
© 2012 Diffusion Pharmaceutical LLC


Charlottesville SEO